Skip to main content

Cells resistant to cytotoxic drugs are recognized by monoclonal antibody

Abstract

A monoclonal antibody produced by hybridomas obtained from a mouse immunized with drug-resistant cells recognizes certain hamster and human drug-resistant cell lines but not their drug-sensitive parental lines. Preliminary characterization of the antigen indicates that it is a molecule of approximately 180,000 daltons. This molecule may be the P-glycoprotein previously associated with a drug-resistance permeability barrier (Riordan JR, Ling V: J Biol Chem 254: 12701–12705, 1979).

This is a preview of subscription content, access via your institution.

References

  1. Calabresi P, Park RE Jr:In The Pharmacological Basis of Therapeutics, AG Gilman, LS Goodman, A Gilman (eds). New York, Macmillan, 1980, pp 1253, 1257–1297

    Google Scholar 

  2. Brockman RW: Circumvention of resistance.In The Pharmacological Basis of Cancer Chemotherapy, RW Cumley, JE McCay (eds). Baltimore, Williams & Wilkins, 1975, pp 691–711

    Google Scholar 

  3. Kessel D, Bosmann HB: On the characterization of actinomycin D resistance in L5178Y cells. Cancer Res 30:2695–2701, 1970

    Google Scholar 

  4. Johnson RK, Chitnis MP, Embrey WM, Gregary EB: In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep 62:1535–1547, 1978

    Google Scholar 

  5. Skovsgaard T: Mechanism of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38:4722–4727, 1978

    Google Scholar 

  6. Wilkoff LJ, Dulmadge EA: Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs and actinomycin D. J Natl Cancer Inst 61:1521–1524, 1978

    Google Scholar 

  7. DiMarco A, Skovsgaard T, Casazza AM, Pratesi G, Nissen NI, Dano K: Cross resistance and cellular uptake of 4′-O-methyldoxorubicin in experimental tumors with acquired resistance to doxorubicin. Cancer Chemother Pharmacol 7:15–20, 1981

    Google Scholar 

  8. Inaba M, Fujikara R, Sakuri Y: Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia. Biochem Pharmacol 30:1863–1865, 1981

    Google Scholar 

  9. Garman D, Center MS: Alterations in cell surface membranes in Chinese hamster lung cells resistant to adriamycin. Biochem Biophys Res Commun 105:57–163, 1982

    Google Scholar 

  10. Biedler JL, Riehm H: Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 30:1174–1184, 1970

    Google Scholar 

  11. Ling V, Thompson LH: Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83:103–116, 1974

    Google Scholar 

  12. Beck WT, Mueller TJ, Tanzer LR: Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39:2070–2076, 1979

    Google Scholar 

  13. Goldie JH, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63:1727–1731, 1979

    Google Scholar 

  14. Salles B, Charcosset JY, Jacquemin-Sablon A: Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Cancer Treat Res 66:327–338, 1982

    Google Scholar 

  15. Kuo T, Pathak S, Ramgli L, Rodriguez L, Hsu TC: Vincristine resistant Chinese hamster ovary cells.In Gene Amplification, RT Schimke (ed). Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1982, pp 53–57

    Google Scholar 

  16. Kartner N, Riordan JR, Ling V: Cell surface P-glycoprotein associated with multidrug resistance in mammalian lines. Science 221:1285–1288, 1983

    Google Scholar 

  17. Conter V, Beck WT: Cross-resistance properties of CCRFCEM cells selected for resistance to vincristine, adriamycin and VM-26. Proc Am Assoc Cancer Res 23:187, 1982

    Google Scholar 

  18. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutant. Biochim Biophys Acta 455:152–162, 1976

    Google Scholar 

  19. Riordan JR, Ling V: Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254:12701–12705, 1979

    Google Scholar 

  20. O'Hara CJ, Price GB: A monoclonal antibody demonstrating specificity for drug-resistant cells. Immunol Lett 5:15–18, 1982

    Google Scholar 

  21. Köhler G, Milstein C: Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion. Eur J Immunol 6:511–519, 1976

    Google Scholar 

  22. Price GB, McCutcheon MS, Taylor WB, Miller RG: Measurement of cytoplasmic fluorescence depolarization of single cells in a flow system. J Histochem Cytochem 25:597–600, 1977

    Google Scholar 

  23. Fairbanks G, Steck TL, Wallach DFH: Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10:2606–2617, 1971

    Google Scholar 

  24. Switzer RC, Merril CR, Shifrin S: A highly sensitive silver stain for detecting proteins and peptide in polyacrylamide gels. Anal Biochem 98:231–237, 1979

    Google Scholar 

  25. Young IT: Proof without prejudice: Use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem 25:935–941, 1977

    Google Scholar 

  26. Ling V: Genetic basis of drug resistance in mammalian cells.In Drug and Hormone Resistance in Neoplasia, N Brachovsky, JH Goldie (eds). Florida, CRC Press, 1983, (in press)

    Google Scholar 

  27. Beck WT, Cirtain MC: Continental expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin and pronase. Cancer Res 42:184–189, 1982

    Google Scholar 

  28. Debenham PG, Kartner N, Siminovitch L, Riordon JR, Ling V: DNA-mediated transfer of multiple drug-resistance and plasma membrane glycoprotein expression. Mol Cell Biol 2:881–889, 1982

    Google Scholar 

  29. Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 270:347–349, 1977

    Google Scholar 

  30. Beran M, Andersson B, Eksborg S, Ehrsson H: Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunrubicinal, and daunorubicin-DNA complex. Cancer Chemother Pharmacol 2:19–24, 1979

    Google Scholar 

  31. Gallo RC, Breitman TR, Ruscetti FW: Proliferation and differentiation of human myeloid leukemia cell lines in vitro.In Maturation Factors and Cancer, MAS Moore (ed). New York, Raven Press, 1982, pp 255–271

    Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

O'Hara, C.J., Grover, J. & Price, G.B. Cells resistant to cytotoxic drugs are recognized by monoclonal antibody. J Clin Immunol 4, 403–411 (1984). https://doi.org/10.1007/BF00917144

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917144

Key words

  • Hybridoma
  • vinca-alkaloids
  • antitumor
  • antibiotics
  • drug resistance